Marc de Gasparo

New basic science initiatives with the angiotensin II receptor blocker valsartan
J Renin Angiotensin Aldosterone Syst 2000 1: S3-S5. [Abstract] [PDF] [References]  

Thomas Unger and Steffen Sandmann

Angiotensin receptor blocker selectivity at the AT1- and AT2-receptors: conceptual and clinical effects
J Renin Angiotensin Aldosterone Syst 2000 1: S6-S9. [Abstract] [PDF] [References]  

Joel M Neutel

Hypertension and its management: a problem in need of new treatment strategies
J Renin Angiotensin Aldosterone Syst 2000 1: S10-S13. [Abstract] [PDF] [References]  

Björn Dahlöf

Valsartan and the renin-angiotensin-aldosterone system: blood pressure control and beyond
J Renin Angiotensin Aldosterone Syst 2000 1: S14-S16. [Abstract] [PDF] [References]  

Gordon T McInnes

Saving lives: long-term morbidity and mortality trials with selective angiotensin receptor blocker therapy
J Renin Angiotensin Aldosterone Syst 2000 1: S17-S20. [Abstract] [PDF] [References]  

Alberto Zanchetti

Cardiac, renal and vascular complications in the diabetic patient
J Renin Angiotensin Aldosterone Syst 2000 1: S21-S24. [Abstract] [PDF] [References]  

Martin P Bedigian

Improving the prognosis of diabetic patients: evaluating the role of intensive versus moderate blood pressure control with selective angiotensin II receptor blocker (ARB) therapy
J Renin Angiotensin Aldosterone Syst 2000 1: S25-S28. [Abstract] [PDF] [References]  

Luis M Ruilope

New clinical investigations with selective angiotensin II receptor blocker therapy in diabetes and renal disease
J Renin Angiotensin Aldosterone Syst 2000 1: S29-S31. [Abstract] [PDF] [References]  

Peter E Carson

The HF epidemic: the need for new treatment strategies
J Renin Angiotensin Aldosterone Syst 2000 1: S32-S34. [Abstract] [PDF] [References]  

Hidenori Urata

Pathological involvement of chymase-dependent angiotensin II formation in the development of cardiovascular disease
J Renin Angiotensin Aldosterone Syst 2000 1: S35-S37. [Abstract] [PDF] [References]  

Jay N Cohn

Rationale for angiotensin II receptor blocker therapy in chronic heart failure
J Renin Angiotensin Aldosterone Syst 2000 1: S38-S40. [Abstract] [PDF] [References]  

Marc A Pfeffer

Will more complete inhibition of the RAAS with angiotensin receptor blockade improve survival following myocardial infarction?
J Renin Angiotensin Aldosterone Syst 2000 1: S41-S43. [Abstract] [PDF] [References]  

To see an article, click its [PDF] link. To add articles to your marked citations, check the boxes to the left of the titles you want, and click the 'Add to Marked Citations' button. To see one abstract at a time, click its [Abstract] link.